4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000066
Senior Vice President, Finance sold 1,587 shares at an average $80.95 ($128,468)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Agarwal Arjun · Senior Vice President, Finance
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-22 | Sale : show line 1 in the form 10b5-1 | −888 | $80.01 | $71,049 | 16,011 | D |
| 2026-06-22 | Sale : show line 2 in the form 10b5-1 | −699 | $82.15 | $57,419 | 15,312 | D |
| Open-market sales · 1,587 sh · avg $80.95 · $128,468 | ||||||
Loading xslF345X06/form4.xml…